ArticleBMB reports2018

LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice.

Jong-Gil Park et al.PubMed ↗Full text ↗

No numbers read from the abstract.